Be the first to like this
Speeding up development time while managing the risk of drug discovery must more than ever be achieved through collaborations between Pharma companies and CRO’s. But How can the quality of outsourced development services be ensured while reducing the financial, operational as well as IP-related risks outsourcing brings along?
At our last Discovery Partnership conference, Dr. Andrew Alexander Parsons, Director at Reciprocal Minds Limited and former VP Preclinical Drug Development and External Discovery at GSK, UK spoke about “The skills, activities and attitudes for successful co-creative collaboration”.
Read the full presentation and find out about:
- Practical skills & theoretical competencies needed for
- How to empower innovation in collaboration
- Risk planning and mitigation
Download this exclusive presentation here: http://bit.ly/slideshare_parsons